Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05603026 · ClinicalTrials.gov registry record · NA
MRI in Transcatheter Aortic Valve Replacement Patients
A NA study of Aortic Valve Stenosis, sponsored by University Hospitals Cleveland Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT05603026 is a NA study of Aortic Valve Stenosis that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 90 participants, below the 1,040-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05603026, a NA study of Aortic Valve Stenosis, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The hypothesis is that SEV result in superior valvular hemodynamics (more pronounced during exercise) and exercise capacity relative to BEV. Furthermore, the hypothesis is that stress CMR will be able to demonstrate differences in these hemodynamic parameters. CMR will also provide refined assessment of paravalvular leak and its impact on ventricular function and on clinical outcomes.
Conditions Studied
Interventions
- DEVICE Self-expanding valve (Medtronic Evolut FX)
- DEVICE Balloon-expanding valve (Edwards Sapien 3 Ultra RESILIA)
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-11-21 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05603026
The ClinicalTrials.gov registry entry for NCT05603026 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,040-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (91% lower). The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Valve Stenosis appearing as the primary indexed condition, and to 2 interventions - of which Self-expanding valve (Medtronic Evolut FX) is the first listed.
NCT05603026 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05603026 about?
NCT05603026 is a clinical study titled "MRI in Transcatheter Aortic Valve Replacement Patients". The hypothesis is that SEV result in superior valvular hemodynamics (more pronounced during exercise) and exercise capacity relative to BEV. Furthermore, the hypothesis is that stress CMR will be able to demonstrate differences in these hemodynamic parameters. CMR will also provide refined assessmen...
What is the current status of trial NCT05603026?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-11-21. Estimated completion is 2026-12-30.
What conditions does trial NCT05603026 study?
This clinical trial studies the following conditions: Aortic Valve Stenosis.
What interventions are being tested in trial NCT05603026?
The interventions under investigation include: Self-expanding valve (Medtronic Evolut FX) (DEVICE), Balloon-expanding valve (Edwards Sapien 3 Ultra RESILIA) (DEVICE).
Who is sponsoring clinical trial NCT05603026?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05603026 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
RECRUITING · NA
-
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
RECRUITING · NA
-
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
RECRUITING · NA
-
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
RECRUITING · NA
-
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.